CA Patent

CA2605341A1 — Modified-release pharmaceutical compositions

Assigned to Amag Pharma USA Inc · Expires 2006-11-16 · 20y expired

What this patent protects

This invention is directed generally to modified-release pharmaceutical compositions, and, more particularly, to modified-release anesthetic- or analgesic- comprising pharmaceutical compositions that are bioadherent to a vaginal cavity surface, vulva surface, or skin. This invent…

USPTO Abstract

This invention is directed generally to modified-release pharmaceutical compositions, and, more particularly, to modified-release anesthetic- or analgesic- comprising pharmaceutical compositions that are bioadherent to a vaginal cavity surface, vulva surface, or skin. This invention also is directed generally to methods for preparing such compositions, methods of treatment using such compositions, uses of such compositions to prepare medicaments, and kits comprising such compositions.

Drugs covered by this patent

Patent Metadata

Patent number
CA2605341A1
Jurisdiction
CA
Classification
—
Expires
2006-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Amag Pharma USA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.